DIAGNOS Inc. News
-
DIAGNOS to Present at Centurion One Capital 8th Annual Toronto Growth Conference
February 24, 2025 (Source) — Diagnos Inc. (TSXV: ADK) (OTCQB: DGNOF) (FSE: 4D4A) (“DIAGNOS” or the “Corporation”), a pioneer…
-
DIAGNOS Announces Closing of Private Placement
February 5, 2025 (Source) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer…
-
DIAGNOS Announces Financial Contribution of $400,000 from the Government of Canada
January 30, 2025 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A),…
-
DIAGNOS to Present at The Microcap Conference 2025
January 28, 2025 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A),…
-
DIAGNOS Announces the Engagement of Promoter
January 13, 2025 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A),…
-
DIAGNOS Announces Cross-listing of its Common Shares on the Frankfurt Stock Exchange
November 12, 2024 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A)…
-
DIAGNOS Announces Closing of Private Placement
October 25, 2024 (Source) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer…
-
DIAGNOS Announces the Engagement of Market Maker Consultant
October 17, 2024 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer…
-
DIAGNOS Announces Grant of Stock Options
October 03, 2024 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer…
-
DIAGNOS Announces Voting Results of Meeting of Shareholders
September 26, 2024 (Source) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer…
